SHE:300642

1 story mentioning SHE:300642Updated 48d ago

Every FINWIRES story that references SHE:300642, newest first.

Tellgen Gets Chinese Provincial Level Approval for Osteoporosis Diagnostic Reagent

Authorities in Jiangxi, China approved two reagents manufactured by Tellgen (SHE:300642) subsidiary Jiangxi TellGen Life Technology, according to a Thursday filing with the Shenzhen bourse.The two reagents help with diagnosing osteoporosis.

SHE:300642

Track with the FINWIRES app suite

FolioX

Track SHE:300642 in your portfolio

WheelAI

Analyze SHE:300642 options with the wheel strategy

StockInsider

See market sentiment on SHE:300642